Status:

COMPLETED

Evaluation of the Analgesic Effect of Dexmedetomidine Versus Fentanyl as Adjuvants to Epidural Bupivacaine in Patients Undergoing Lumbar Spine Surgeries

Lead Sponsor:

Cairo University

Collaborating Sponsors:

Mohamed, Ahmed A., M.D.

Tarek Ahmed Radwan

Conditions:

Dexmedetomidine VS Fentanyl as Adjuvants to Epidural Bupivacaine in Patients Undergoing Lumbar Spine Surgeries

Eligibility:

MALE

18-65 years

Phase:

NA

Brief Summary

To determine if the epidural route provide an acceptable analgesia in spine surgeries and avoided the need for excessive IV analgesics. Also to determine whatever dexmedetomidine or fentanyl is more b...

Detailed Description

Relieving post-operative pain of spine surgeries has become an indispensable component in anesthesiology. Various methods have been tried for the management of post-operative pain in spine surgeries o...

Eligibility Criteria

Inclusion

  • All male patients between the age group of 18 and 65 years
  • Patients of American Society of Anaesthesiologists (ASA) class I and II.
  • Patients who will undergo lumbar spine surgeries (laminectomy ± discectomy for PIVD (Prolapse of intervertebral disc), will be enrolled for this study

Exclusion

  • All Patients below the age of 18 years and above 65 years. Also All female patient are excluded from the study.
  • Other spine surgeries rather than laminectomy, also surgeries on more than two levels.
  • Patients with haematological disease, bleeding or coagulation test abnormalities, psychiatric diseases.
  • 4 .Patiensts with history of drug abuse, allergy to any study medication. . 4 .Patients with cervical and thoracic spine surgeries, tubercular spine , any permanent neurological disorders and vertebral deformeties such as scoliosis and spondylolisthesis.
  • 5\. Pregnant and lactating patients .
  • Withdrawal criteria :
  • Accidental Dural puncture.

Key Trial Info

Start Date :

March 4 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 6 2018

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT03463083

Start Date

March 4 2018

End Date

May 6 2018

Last Update

May 30 2018

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Ahmed Abdalla Mohamed

Cairo, Egypt, 11451